An atrial fibrillation patient with high CHA2DS2-VASc Score, a gastrointestinal bleed and renal impairment - How to implement the Guidelines.

28 August 2018 (09:45 - 09:55)

Organised by:

Video

Sign in for access options

Slides

7 More presentations in this session

Presentation thumbnail

Case 1: an atrial fibrillation patient needing combination antiarrhythmic drug treatment

Professor G. Dan (Bucharest, RO)

Presentation thumbnail

An atrial fibrillation patient needing combination antiarrhythmic drug treatment - What do the Guidelines say?

Professor P. Kirchhof (Hamburg, DE)

Presentation thumbnail

An atrial fibrillation patient needing combination antiarrhythmic drug treatment - How to implement the Guidelines.

Presentation thumbnail

An atrial fibrillation patient needing combination antiarrhythmic drug treatment - Conclusion and take home message.

Professor N. Marrouche (New Orleans, US)

Presentation thumbnail

Case 2: an atrial fibrillation patient with high CHA2DS2-VASc Score, a gastrointestinal bleed and renal impairment

Doctor M. Akao (Kyoto, JP)

Access the full session

Session thumbnail

Atrial fibrillation: from Guidelines to clinical practice

The Event

ESC Congress 2018

28 August 2018 09:45 CET

You may be interested in

Congress Presentation

NOAC patient journey: i.e. bridging, ACS/PCI, renal dysfunction and comedication.

3 April 2022

Congress Presentation

Bleeding risks with frailty and multimorbidity in patients with atrial fibrillation. A nationwide analysis of 1.4 million subjects

31 August 2020

Congress Presentation

Edoxaban treatment in real-world practice is highly concordant with ESC atrial fibrillation guidelines: results from the non-interventional global ETNA-AF program

27 August 2021

Congress Presentation

2 September 2019

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources